News Pfizer cholesterol drug succeeds in two late stage trials Pfizer's bococizumab cholesterol drug has met primary endpoint in two phase 3 trials, part of a series of six late-stage studies.
Digital Seeking effective, safe treatment for all with precision dos... Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
